EUVIMEDEUVIMED entdecken
Crossref

Serum progranulin: A potential marker of SLE activity

Nancy S Wahba, Yasser A Zeitoun, Dina A Soliman, Dalia M Gamal, Mirette E Attia, Fatma A. A. Mahmoud

The Egyptian journal of Immunology · 2026

DOI: 10.55133/eji.330102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian journal of Immunology, 2026. Verfasst von Nancy S Wahba und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo Egypt. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Intercellular Signaling Peptides and Proteins.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The assessment of systemic lupus erythematosus (SLE) disease activity is considered a challenge to patients and physicians. In the last few years, there was evidence that progranulin (PGRN) may be involved in the pathogenesis of SLE, so, it might be a suitable marker for the assessment of disease activity. In this study, we aimed to identify the role of PGRN in SLE pathogenesis and its association with disease activity and organ damage. This case-control study included 50 SLE patients, 20 patients with autoimmune diseases other than SLE, and 20 apparently healthy adults as a control group. The concentration of serum PGRN was assayed in all studied participants by using quantitative enzyme-linked immunosorbent assay. The results showed that serum PGRN levels were significantly higher among SLE patients when compared to the group of patients with autoimmune diseases other than SLE, as well as when compared to the control group. There was a significant positive correlation of serum PGRN levels of SLE patients with erythrocyte sedimentation rate, 24 hours urine protein, SLE disease activity index (SLEDAI)-2k score, and SLICC/ACR damage index (SDI) score; while there was a negative correlation with C3, C4 and hemoglobin concentrations. Thus, we concluded that serum PGRN could be a useful biomarker of SLE disease activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicIntercellular Signaling Peptides and ProteinsHumansProgranulinsBiomarkersFemaleAdultMaleCase-Control StudiesMiddle AgedEnzyme-Linked Immunosorbent AssayBlood SedimentationSeverity of Illness IndexYoung Adult

Substanzen

ProgranulinsBiomarkersIntercellular Signaling Peptides and ProteinsGRN protein, human

Autor:innen und Institutionen

  • Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo Egypt.
  • Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo Egypt.

Zitieren

APA

Wahba, N. S., Zeitoun, Y. A., Soliman, D. A., Gamal, D. M., Attia, M. E., & Mahmoud, F. A. A. (2026). Serum progranulin: A potential marker of SLE activity. The Egyptian journal of Immunology. https://doi.org/10.55133/eji.330102

Vancouver

Wahba NS, Zeitoun YA, Soliman DA, Gamal DM, Attia ME, Mahmoud FAA. Serum progranulin: A potential marker of SLE activity. The Egyptian journal of Immunology. 2026. doi:10.55133/eji.330102

BibTeX
@article{Wahba2026,
  author = {Wahba, Nancy S and Zeitoun, Yasser A and Soliman, Dina A and Gamal, Dalia M and Attia, Mirette E and Mahmoud, Fatma A. A.},
  title = {Serum progranulin: A potential marker of SLE activity},
  journal = {The Egyptian journal of Immunology},
  year = {2026},
  doi = {10.55133/eji.330102}
}
Kostenlos starten →